The new mutation of the Coronavirus, called the WHO omicron and first notified by South Africa on November 24, has already identified in Europe, with a case confirmed in Belgium, after being reported in South Africa, Botswana, Hong Kong and Israel.
WHO said that it could take several weeks to determine if the new variant involves changes in the transmissibility or severity of the Covid-19, as well as in the effectiveness of vaccines, testing and treatments of the COVID-19, and warned against the imposition of
Travel restrictions while scientific evidence is scarce.

Total figures: 5,131,012 cases of coronavirus confirmed with diagnostic test of active infection;
There have been 87,955 dead with positive test to November 26, 2021.

The modern American pharmaceutical has announced that it works in a reinforcement of the specific vaccine for the omicron variant, under a strategy designed to face this variant detected for the first time in South Africa that has already been rated as “worrying” by the World Organization
of health (WHO).

In a statement, modern has pointed out that the newly appointed omicron presents a combination of mutations representing a “significant potential risk to accelerate the reduction of natural immunity and induced by vaccines”.

Faced with this, “a reinforcement dose of an authorized vaccine represents the only strategy currently available to increase routing immunity,” so they are working “quickly” to prove the capacity of your current vaccine to “neutralize variant” and expect
Being able to get more data in the coming weeks on the result.

The United States, Brazil and countries of all regions of the world announced on Friday the closure of its borders to travelers from South Africa, after detecting a new variant of potentially very contagious coronavirus called omicron.

The World Health Organization (WHO) stated that CORONAVIRUS B.1.1.529 strain, which called omicron, is a “worrisome” variant as well as the currently dominated Delta and those previously detected alpha, Beta and Gama.

The new mutation, notified for the first time by South Africa on November 24, has already identified in Europe, with a case confirmed on Friday in Belgium, after being reported in South Africa, Botswana, Hong Kong and Israel.

From actions to oil, world markets collapsed with the news about omicron, before fears of a hard blow to global economic recovery.